IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens
about
Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifsDiversity of IL-17-producing T lymphocytesBeneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive SetupDifferences in Susceptibility to Heat Stress along the Chicken Intestine and the Protective Effects of Galacto-OligosaccharidesIL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regenerationIL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerMuc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen.The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection.Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB.Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.IL-6 stimulates intestinal epithelial proliferation and repair after injury.The pathogenicity of an enteric Citrobacter rodentium Infection is enhanced by deficiencies in the antioxidants selenium and vitamin E.Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection.A balanced IL-1β activity is required for host response to Citrobacter rodentium infection.Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin.Non-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responsesModulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null miceImmunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentiumSTAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway.Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen.Functions of innate immune cells and commensal bacteria in gut homeostasis.THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM.Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6.Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditionsCXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen.The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses.Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens.Trp53 deficiency protects against acute intestinal inflammation.Divergent Annexin A1 expression in periphery and gut is associated with systemic immune activation and impaired gut immune response during SIV infection.
P2860
Q24299272-ABB7A331-87F0-4AE3-9C87-84ED5F270218Q27010199-CC37C5BF-E324-426E-95FF-82ED9D1F0309Q27315053-9C09C98E-60B8-4C40-BDB8-83FFEFD4C539Q27316495-3927A500-2AD3-493D-940B-048092A92A03Q28534312-E5322FE2-1E45-4A40-B2D0-198CFF467494Q29614594-EE8E5173-7152-4351-BF58-D1440AAAD652Q33582232-56355F67-927E-4DCD-B59A-670DE71B42C4Q33675794-42DDF3E9-CE46-457A-BB38-6E63CDCC8F63Q33728144-8973CAC8-B4C5-41C7-AC36-8C0B50FCF9A1Q33820227-83823CB5-B708-4CB4-A6A5-DAC6C6378164Q34018620-80845B7E-EFF6-47BF-9AC3-0EFF386618B5Q34058590-F2B4A4CD-D24A-4FE6-A772-962E1947E721Q34226867-C65EC46D-2CAC-4478-9DF2-18003282D4EDQ34294123-9842ED37-72CB-4A5D-83F3-B2FA8390F6DFQ34298295-00FC79F9-F489-4075-A0D6-0C22375FE315Q34640584-DD874E92-74F6-4F4F-AD8E-1D3D5E53F711Q34740127-2AC86D7B-A4A5-4066-BBFE-34A3A53DA6D2Q34876594-E6C0EFD2-037C-49EC-9B9E-AF14540E8A3CQ34931410-61628814-4F5D-43F4-B1EC-CF5FE6205AF4Q35061095-86726F03-1F22-4B0E-B37C-662FED6A1757Q35191960-F867DC14-120A-44D7-97E4-F9E0A253BA5BQ35365098-4DE66091-A566-4132-9496-241F73082EF5Q35454343-2FFDD906-7BA7-4E5F-A224-86649C517C3EQ35530236-1EC0288B-B6A8-47BA-A644-D295E3F9D50AQ35589806-2EE2D67C-25D6-435D-9EDB-48AA6163EA34Q35646070-8BAC68F7-33CB-445D-8494-DC92E01D8674Q35833835-F37D19FB-43F5-4D62-9FDD-D484E9E8008DQ35854795-4B63EC4D-209B-4475-ACD0-4FE83100D184Q35869432-C9A63E93-F1C8-400F-A5B7-9906D3B9F670Q35964497-9533637E-51F6-426A-A812-49564A3A138AQ36093753-8B858BA3-873E-4B99-9111-4C1583485E3EQ36161896-FB5F0245-C698-4B0B-A4C5-59610DBBF16FQ36166383-679CC66B-2197-474E-AB63-8C1F6DAC79A6Q36200507-8A2738D7-4598-410F-B4ED-35668C90A939Q36211058-E06FD6B9-66AE-4596-96A9-C6999E366FC4Q36237164-9924500F-C7E8-4C14-9988-95739D9A55DDQ36494694-757FABD6-9116-46B2-8513-458AB60E1AD2Q36646618-81353900-9FAE-4454-AF7D-AFFC90756719Q37008316-6A3E2306-E058-4811-AA2C-8D3AAF94AD3CQ37147916-5B630907-32A3-47B7-9A99-F14F98DFE3A9
P2860
IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-6-dependent mucosal protect ...... ng enteric bacterial pathogens
@en
IL-6-dependent mucosal protect ...... g enteric bacterial pathogens.
@nl
type
label
IL-6-dependent mucosal protect ...... ng enteric bacterial pathogens
@en
IL-6-dependent mucosal protect ...... g enteric bacterial pathogens.
@nl
prefLabel
IL-6-dependent mucosal protect ...... ng enteric bacterial pathogens
@en
IL-6-dependent mucosal protect ...... g enteric bacterial pathogens.
@nl
P2093
P2860
P1476
IL-6-dependent mucosal protect ...... ng enteric bacterial pathogens
@en
P2093
Dustin C Hammond
Elaine Hanson
Lars Eckmann
Lillian J Choi
Martina E Spehlmann
Mitsutoshi Iimura
Sara M Dann
P2860
P304
P356
10.4049/JIMMUNOL.180.10.6816
P407
P577
2008-05-01T00:00:00Z